“…Recently, 2,4,6-trisubstituted-1,3,5-triazine scaffolds were discovered as a potent inhibitors of Mycobacterium tuberculosis H37Rv [10]. Currently 1,3,5-triazine derivatives have been found to possess wide range of biological activities, such as adenosine receptor antagonist [11], antiamoebic [12], anticancer [13], antileishmanial [14], antimalarial [15], antimicrobial [16], antiviral [17], antitubercular [18], carbonic anhydrase inhibitor [19], cathepsin B inhibitor [20], cholesteryl ester transfer protein inhibitor [21], corticotropin-releasing factor ligand [22], CRF1 PET imaging agent [23], cytosolic phospholipase A2α inhibitor [24], dipeptidyl peptidase IV inhibitor [25], bacterial enzyme DNA helicase inhibitor [26], dual PI3/mTOR inhibitor [27], glucocerebrosidase inhibitor [28], α-glucosidase inhibitor [29], growth factor inhibitor [30], human gonadotropin-releasing hormone receptor antagonist [31], 5-HT7 receptor antagonist [32], inosine monophosphate dehydrogenase inhibitor [33], mTOR kinase inhibitor [34], voltage-gated sodium channel Nav 1.7 antagonist [35], neuronal voltage-gated sodium channel blocker [36], phosphodiesterase type 4 inhibitor [37], protein kinase CK2 inhibitor [38], ROCK inhibitor [39], β-secretase inhibitor [40], sorbitol dehydrogenase inhibitor [41], tryptophan hydroxylase inhibitor [42] and VLA-4 integrin antagonist [43]. Similarly, azomethine moiety has gained a great importance, since it has been found to possess several biological activities, such as antimicrobial [44]…”